2018 American Transplant Congress
Single vs. Multi-Drug Antibiotic Prophylaxis for Continuous-Flow Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis
Purpose: Despite the fact that infection remains a major complication of continuous-flow left ventricular assist device (CF-LVAD) therapy, an optimal antimicrobial surgical infection prophylaxis (SIP)…2018 American Transplant Congress
The Net State of Immunosuppression in Septuagenarian Liver Transplant Recipients: Balancing Rejection and Infection Risks
Purpose: Careful patient selection and perioperative management have allowed for successful liver transplantation in elderly patients. Elderly patients may be more susceptible to the infectious…2018 American Transplant Congress
Treatment of Multi-Drug Resistant Gram Negative Infections after Solid Organ Transplant
Comprehensive Transplant Center, Northwestern University, Chicago, IL.
Introduction: Infections with multi-drug resistant (MDR) gram-negative bacilli are associated with significant morbidity and mortality after solid organ transplant. This study characterized patient outcomes related…2018 American Transplant Congress
Infectious Complications Associated with Eculizumab Used for ABO-Incompatible Renal Transplantation
University of Illinois at Chicago, Chicago.
Introduction: A novel approach in ABO-incompatible (ABOi) living donor renal transplant (LDRT) includes use of eculizumab (ECU) that allows for avoidance of traditional desensitization. We…2018 American Transplant Congress
Containment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections at a Solid Organ Transplant Centre
1ISMETT-IRCCS, Palermo, Italy; 2University of Insubria, Varese, Italy.
Objectives The aim is to describe epidemiology and analyze the effectiveness of the intervention in CRE containment in SOT patients (pts).Methods In 2012 a taskforce…2018 American Transplant Congress
Standard- versus Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Kidney Transplant Recipients
Henry Ford Hospital, Detroit, MI.
Background: Although guidelines recommend valganciclovir (VGC) 900 mg daily for cytomegalovirus (CMV) prophylaxis in solid organ transplant patients, multiple centers have reported clinical success, reduced…2018 American Transplant Congress
Cytomegalovirus Prophylaxis Following Alemtuzumab Induction in High Risk Renal Transplant Recipients Experiencing Delayed Graft Function
University of Maryland, Baltimore.
Purpose: There is limited data to support the use of valganciclovir in patients on dialysis. This study assessed the efficacy of valganciclovir 450 mg twice…2018 American Transplant Congress
Clinical Utility of CMV-Specific CD8+ T-Cell Immune Competence Score in Lung and Heart-Lung Transplant Recipients at Risk of Cytomegalovirus Infection
Introduction: Cytomegalovirus (CMV) is a common infection that causes significant morbidity among lung and heart-lung (LHL) transplant recipients. We determined the clinical utility of global…2018 American Transplant Congress
Timing of Infections after Total Artificial Heart Implantation. What Did We Learn?
Transplant Infectious Diseases, University of Nebraska Medical Center, Omaha, NE.
Background: The total artificial heart (TAH) has become a reliable bridge to heart transplantation. There are no studies describing the timing of infections post-TAH implantation.…2018 American Transplant Congress
Latent Tuberculosis Diagnosis Prior to Kidney Transplantation in a High Burden Country: Improvement with Serological Tests
Nephrology and Kidney Transplant Department, ISCMPA, Porto Alegre, Brazil.
Introduction: Diagnosing and treating tuberculosis after kidney transplantation is challenging, and mortality is high. In an epidemiological study performed at our Center, there was an…
- « Previous Page
- 1
- …
- 49
- 50
- 51
- 52
- 53
- …
- 84
- Next Page »